PF-Atlas › Clinical Trials › NCT03115619

Quality of Life Study in Participants With IPF Under Pirfenidone Treatment

Pirfenidone · Not specified

Registry ID
NCT03115619
Phase
Not specified
Status
Completed
Drug / intervention
Pirfenidone
Sponsor
Hoffmann-La Roche
Start
2017-04-18
Enrollment
102
Locations
7

About this trial

This multicenter, post-marketing, observational study will evaluate quality of life in participants with Idiopathic Pulmonary Fibrosis (IPF) under treatment with pirfenidone (Esbriet).

View NCT03115619 on ClinicalTrials.gov →

Explore related

All Pirfenidone trialsAll IPF trials

Related trials

Pirfenidone — NCT00001959pirfenidone — NCT00662038Pirfenidone — NCT02951429Pirfenidone — NCT00287729Pirfenidone — NCT01504334Pirfenidone — NCT02932566
Medical disclaimer. This page summarizes public trial data for NCT03115619 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.